AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2023
Aug 24, 2023
31676_dirs_2023-08-23_07c1de74-d607-440b-8975-f49de748ca0f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2023-08-21
Reporting Person: Leonard Matthew J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-21 | Common Stock | A | 7583 | — | Acquired | 7583 | Direct |
Footnotes
F1: Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of the date of grant.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3